Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33929526.
- Also identified by DOI 10.1001/jamanetworkopen.2021.8530 and PMC identifier 8087952.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study uses data from the US Food and Drug Administration (FDA) to review the postmarketing requirements and commitments attached to new vaccines approved for use in the past 15 years in the United States.
Medical subject headings
- Drug Approval
- Product Surveillance, Postmarketing
- Research
- Social Control, Formal
- United States Food and Drug Administration
- Vaccines